Fulcrum Therapeutics
Price & Volume
Stats
See more52W Range | $2.83-$15.73 |
Market Cap | $287.6M |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | -$56.1M |
Diluted EPS | -$1.21 |
News
See moreYahoo Finance • last month
Slate Medicines Starts Migraine Treatment Study
Yahoo Finance • 2 months ago
Fulcrum Therapeutics & Slate Medicines Merge for Next-Generation Migraine Therapies
Yahoo Finance • 4 months ago
Levi & Korsinsky Announces Investigation of Securities Claims Against Fulcrum Therapeutics, Inc. (FULC)
About
CEO | Mr. Alexander C. Sapir |
CFO | Mr. Alan A. Musso C.M.A., CPA |
Address | 26 Landsdowne Street, Cambridge, MA, United States, 02139 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 9 |